Cerbai C - Search Results

1

Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity.

Greto D, Loi M, Stocchi G, Salvestrini V, Muratori F, Scoccianti G, Roselli G, Palomba A, Lorenzetti V, Cerbai C, Desideri I, Francolini G, Bonomo P, Campanacci DA, Livi L. Greto D, et al. Among authors: cerbai c. Cancer J. 2021 Nov-Dec 01;27(6):423-427. doi: 10.1097/PPO.0000000000000551. Cancer J. 2021. PMID: 34904803

2

Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer.

Ratosa I, Orazem M, Scoccimarro E, Steinacher M, Dominici L, Aquilano M, Cerbai C, Desideri I, Ribnikar D, Marinko T, Livi L, Meattini I. Ratosa I, et al. Among authors: cerbai c. Clin Breast Cancer. 2020 Dec;20(6):495-502. doi: 10.1016/j.clbc.2020.05.013. Epub 2020 May 26. Clin Breast Cancer. 2020. PMID: 32622736

3

Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial.

Bonomo P, Desideri I, Mangoni M, Saieva C, Loi M, Becherini C, Cerbai C, Ganovelli M, Salvestrini V, Stocchi G, Zani M, Palomba A, Livi L. Bonomo P, et al. Among authors: cerbai c. Radiother Oncol. 2022 Apr;169:64-70. doi: 10.1016/j.radonc.2022.02.008. Epub 2022 Feb 11. Radiother Oncol. 2022. PMID: 35157978 Clinical Trial.

4

Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719).

Francolini G, Detti B, Di Cataldo V, Garlatti P, Aquilano M, Allegra A, Lucidi S, Cerbai C, Ciccone LP, Salvestrini V, Stocchi G, Guerrieri B, Visani L, Loi M, Desideri I, Mangoni M, Meattini I, Livi L. Francolini G, et al. Among authors: cerbai c. Radiol Med. 2022 Aug;127(8):912-918. doi: 10.1007/s11547-022-01511-7. Epub 2022 Jun 28. Radiol Med. 2022. PMID: 35763249 Free PMC article. Clinical Trial.

5

Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).

Francolini G, Loi M, Ciccone LP, Detti B, Di Cataldo V, Pinzani P, Salvianti F, Salvatore G, Sottili M, Santini C, Frosini G, Visani L, Burchini L, Mattioli C, Allegra AG, Valzano M, Cerbai C, Aquilano M, Salvestrini V, Desideri I, Mangoni M, Meattini I, Livi L. Francolini G, et al. Among authors: cerbai c. Med Oncol. 2022 Jun 10;39(8):119. doi: 10.1007/s12032-022-01756-2. Med Oncol. 2022. PMID: 35687207

6

Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy?

Huguet F, Cerbai C, Ta MH, Sarrade T, Evin C, Aziez S, Rivin Del Campo E, Durand B, Loi M. Huguet F, et al. Among authors: cerbai c. Cancer Radiother. 2022 Oct;26(6-7):858-864. doi: 10.1016/j.canrad.2022.06.020. Epub 2022 Aug 17. Cancer Radiother. 2022. PMID: 35987811 Review.

7

A narrative review of postoperative adjuvant radiotherapy for non-small cell lung cancer.

Olmetto E, Perna M, Cerbai C, Aquilano M, Banini M, Mariotti M, Livi L, Scotti V. Olmetto E, et al. Among authors: cerbai c. Mediastinum. 2022 Mar 25;6:4. doi: 10.21037/med-21-31. eCollection 2022. Mediastinum. 2022. PMID: 35340837 Free PMC article. Review.

8

Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review.

Banini M, Salvestrini V, Vultaggio A, Perlato M, Mecheri V, Cerbai C, Scotti V, Matucci A, Mangoni M, Livi L, Bonomo P. Banini M, et al. Among authors: cerbai c. Curr Oncol. 2023 Jul 14;30(7):6699-6707. doi: 10.3390/curroncol30070491. Curr Oncol. 2023. PMID: 37504351 Free PMC article. Review.

9

Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group.

Marano L, Marmorino F, Desideri I, Carbone L, Rizzo A, Salvestrini V, Roviello F, Cinieri S, Donato V, De Luca R; NutriOnc Research Group. Marano L, et al. Front Nutr. 2023 Apr 14;10:1045022. doi: 10.3389/fnut.2023.1045022. eCollection 2023. Front Nutr. 2023. PMID: 37125048 Free PMC article.

10

Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer.

Visani L, Livi L, Ratosa I, Orazem M, Ribnikar D, Saieva C, Becherini C, Salvestrini V, Scoccimarro E, Valzano M, Cerbai C, Desideri I, Bernini M, Orzalesi L, Nori J, Bianchi S, Morandi A, Meattini I. Visani L, et al. Among authors: cerbai c. Radiother Oncol. 2022 Dec;177:40-45. doi: 10.1016/j.radonc.2022.10.023. Epub 2022 Oct 28. Radiother Oncol. 2022. PMID: 36349599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page